The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Current and future burden of breast cancer: Global statistics for 2020 and 2040
Open accessAbstract
BACKGROUND: Breast cancer is the most commonly diagnosed cancer worldwide, and its burden has been rising over the past decades. In this article, we examine and describe the global burden of breast cancer in 2020 and predictions for the year 2040. METHODS: Estimates of new female breast cancer cases and deaths in 2020 were abstracted from the GLOBOCAN database. Age-standardized incidence and mortality rates were calculated per 100,000 females by country, world region, and level of human development. Predicted cases and deaths were computed based on global demographic projections for the year 2040. RESULTS: Over 2.3 million new cases and 685,000 deaths from breast cancer occurred in 2020. Large geographic variation across countries and world regions exists, with incidence rates ranging from <40 per 100,000 females in some Asian and African countries, to over 80 per 100,000 in Australia/New Zealand, Northern America, and parts of Europe. Smaller geographical variation was observed for mortality; however, transitioning countries continue to carry a disproportionate share of breast cancer deaths relative to transitioned countries. By 2040, the burden from breast cancer is predicted to increase to over 3 million new cases and 1 million deaths every year because of population growth and ageing alone. CONCLUSION: Breast cancer is the most common cancer worldwide and continues to have a large impact on the global number of cancer deaths. Global efforts are needed to counteract its growing burden, especially in transitioning countries where incidence is rising rapidly, and mortality rates remain high.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Breast cancer has become the most commonly diagnosed cancer worldwide, surpassing lung cancer [1, 2].”
From Nanosensitizer-assisted sonodynamic therapy for breast cancer (2025) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“In terms of primary prevention, a reduction in excess body weight and alcohol consumption and increasing physical activity and breastfeeding may have an impact in reducing breast cancer incidence.58”
From Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. (2024) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Self-citationCancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Writing Group for the Women's Health Initiative Investigators (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.3.321 · Cited by 15,889
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Ferlay, J., Colombet, M., Soerjomataram, I., Mathers, C., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2019) · International Journal of Cancer · doi:10.1002/ijc.31937 · Cited by 7,553
Self-citationCancer statistics for the year 2020: An overview
Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D. M., Piñeros, M., Znaor, A., & Bray, F. (2021) · International Journal of Cancer · doi:10.1002/ijc.33588 · Cited by 6,308
Self-citationAllemani, C., Matsuda, T., Di Carlo, V., Harewood, R., Matz, M., Nikšić, M., Bonaventure, A., Valkov, M., Johnson, C. J., Estève, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33326-3 · Cited by 6,145
Breast cancer statistics, 2019
Desantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Sauer, A. G., Jemal, A., & Siegel, R. L. (2019) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,222
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Breast-Cancer Screening — Viewpoint of the IARC Working Group
Secretan, B., Scoccianti, C., LOOMIS, D. P., Benbrahim‐Tallaa, L., Bouvard, V., Bianchini, F., & Straíf, K. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1504363 · Cited by 966
Flagged first, then by citations
1 of the 43 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 1,000
Chen, Y., Liu, R., Xiao, J., Wang, Y., Yang, Y., Fan, H., Li, D. D., Xu, C., Yan, X., Chen, M., et al. (2024) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2024.102664 · Cited by 15
Chou, C.-Y., Shen, T.-T., Wang, W., & Wu, M. (2024) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2023.11.012 · Cited by 15
Development of a humanized anti-FABP4 monoclonal antibody for potential treatment of breast cancer
Hao, J., Jin, R., Yi, Y., Jiang, X., Yu, J., Xu, Z., Schnicker, N., Chimenti, M. S., Sugg, S. L., & Li, B. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01873-y · Cited by 19
Biogenic nanoparticles: pioneering a new era in breast cancer therapeutics—a comprehensive review
Bhat, S. A., Kumar, V., Dhanjal, D. S., Gandhi, Y., Mishra, S. K., Singh, S., Webster, T. J., & Ramamurthy, P. C. (2024) · Discover Nano · doi:10.1186/s11671-024-04072-y · Cited by 15
Aslam, A., Mustafa, A. G., hussnain, A., Saeed, H., Nazar, F., Amjad, M., Mahmood, A., Afzal, A., Fatima, A., & Alkhalidi, D. K. (2024) · International Journal of Breast Cancer · doi:10.1155/2024/2128388 · Cited by 15
Sadr, S., Hajjafari, A., Rahdar, A., Pandey, S., Jafroodi, P. P., Lotfalizadeh, N., Soroushianfar, M., Kavasebi, S. S., Kharaba, Z. J., Fathi‐karkan, S., et al. (2024) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2024.100238 · Cited by 16
Gui, G., Yang, D.-J., Liu, Y., Yao, Y.-S., Xie, X., Liu, R., Liu, M., Liu, H.-M., & Zhou, F.-F. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1567485 · Cited by 15
Screening programmes and breast cancer mortality: an observational study of 194 countries
Hasan, S. M. A., Bennett, D. L., & Toriola, A. T. (2025) · Bulletin of the World Health Organization · doi:10.2471/blt.24.292529 · Cited by 15
Depression risk among breast cancer survivors: a nationwide cohort study in South Korea
Choi, H. L., Jeong, S. M., Jeon, K. H., Kim, B., Jung, W., Jeong, A., Han, K., & Shin, D. W. (2024) · Breast Cancer Research · doi:10.1186/s13058-024-01948-w · Cited by 14
Imam, M., Ji, J., Zhang, Z., & Yan, S. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1493188 · Cited by 18
Sinha, A., Jurrius, P., van Schelt, A., Darwish, O. I., Shifa, B., Annio, G., Peterson, Z., Jeffery, H., Welsh, K., Metafa, A., et al. (2025) · Radiology Imaging Cancer · doi:10.1148/rycan.240138 · Cited by 16
Histone acetylation modulators in breast cancer
Yuan, X., & Rosen, J. M. (2025) · Breast Cancer Research · doi:10.1186/s13058-025-02006-9 · Cited by 14
Perturbing local steroidogenesis to improve breast cancer immunity
Zhao, Q., Pramanik, J., Lu, Y., Homer, N. Z. M., Imianowski, C. J., Zhang, B., Iqbal, M., Shaji, S. K., Morris, A. C., Roychoudhuri, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59356-3 · Cited by 15
Racial and Socioeconomic Disparity in Breast Cancer Mortality: A Systematic Review and Meta-Analysis
Ribeiro, H. F., Pelloso, F. C., da Fonseca, B. S., Camparoto, C. W., Carvalho, M. D. D. B., Marques, V. D., Bitencourt, M. R., Stevanato, K. P., Borba, P. B., Borghesan, D. H. P., et al. (2025) · Cancers · doi:10.3390/cancers17101641 · Cited by 14
El-Rashedy, A. A. E., Ibrahim, N. E., Abo‐Salem, H. M., Elaasser, M. M., & El-Sawy, E. R. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108677 · Cited by 14
Sánchez-Ocaña, M., & de Porras, V. R. (2025) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2025.104834 · Cited by 15
Autophagy modulation in breast cancer utilizing nanomaterials and nanoparticles
Gharoonpour, A., Simiyari, D., Yousefzadeh, A., Badragheh, F., & Rahmati, M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1150492 · Cited by 14
Nafeh, G., Akl, M. A., Samarani, J., Bahous, R., Kari, G. A., Younes, M., Sarkis, R., & Rizk, S. E. (2023) · Pharmaceuticals · doi:10.3390/ph16060780 · Cited by 14
Computational model for breast cancer diagnosis using HFSE framework
Kumari, D., Yannam, P. K. R., Gohel, I. N., Naidu, M. V. S. S., Arora, Y., Rajita, B. S. A. S., Panda, S., & Christopher, J. J. (2023) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.105121 · Cited by 14
Li, J., Fu, R., Guo, X., Pan, Z., & Xie, J. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07967-1 · Cited by 14
DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?
Timbres, J., Kohut, K., Caneppele, M., Troy, M., Schmidt, M. K., Roylance, R. R., & Sawyer, E. J. (2023) · Cancers · doi:10.3390/cancers15174397 · Cited by 14
Gebremariam, A., Addissie, A., Worku, A., Dereje, N., Assefa, M., Kantelhardt, E. J., & Jemal, A. (2023) · JCO Global Oncology · doi:10.1200/go.23.00148 · Cited by 14
Goodarzi, K., Lane, R., & Rao, S. S. (2023) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37651 · Cited by 14
Zhang, J., Sun, Y., Ren, L., Chen, L., Nie, L., Shavandi, A., Yunusov, K. E., Aharodnikau, U. E., Solomevich, S. O., & Jiang, G. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01239 · Cited by 14
Quang, D. T., Thi, T. L., Di, K. N., Quynh, C. V. T., Hoa, H. N. T., & Ngoc, Q. P. (2024) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2024.101062 · Cited by 17
Ambient air pollutants and breast cancer stage in Tehran, Iran
Khorrami, Z., Pourkhosravani, M., Karamoozian, A., Jafari-Khounigh, A., Akbari, M. E., Rezapour, M., Khorrami, R., Shahri, S. M. T., Amini, H., Etemad, K., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-53038-8 · Cited by 14
Sezer, G., Şahin, F., Önses, M. S., & Cumaoğlu, A. (2024) · Talanta · doi:10.1016/j.talanta.2024.125827 · Cited by 14
Azizi, A., Mehdipour, F., Samadi, M., Rasolmali, R., Talei, A., & Ghaderi, A. A. (2024) · BMC Immunology · doi:10.1186/s12865-024-00620-4 · Cited by 14
Yu, T., Yu, R., Liu, M., Wang, X., Zhang, J., Zheng, Y., & Lv, F. (2024) · European Journal of Radiology · doi:10.1016/j.ejrad.2024.111556 · Cited by 14
Kim, H., Hong, B., Kim, S., Kang, S., & Park, J. (2024) · Systematic Reviews · doi:10.1186/s13643-024-02588-z · Cited by 15
Wang, H., Cao, Y., Zhang, L., Zhao, Q., Li, S., & Li, D. (2024) · Clinical Breast Cancer · doi:10.1016/j.clbc.2024.09.006 · Cited by 15
Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer
Padzińska-Pruszyńska, I. B., Kucharzewska, P., Matejuk, A., Górczak, M., Kubiak, M., Taciak, B., & Król, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910781 · Cited by 15
Rhodanine–Piperazine Hybrids as Potential VEGFR, EGFR, and HER2 Targeting Anti-Breast Cancer Agents
Szczepański, J., Khyluk, D., Korga-Plewko, A., Michalczuk, M., Mańdziuk, S., Iwan, M., & Trotsko, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212401 · Cited by 14
Multispectral photoacoustic imaging of breast cancer tissue with histopathology validation
Zhang, J., Arroyo, J., & Bell, M. A. L. (2025) · Biomedical Optics Express · doi:10.1364/boe.547262 · Cited by 14
Tian, L., Wen, Y., Li, T., Liu, C., & Fan, J. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2499027 · Cited by 17
Citarella, A., Besharat, Z. M., Coppola, L., Sabato, C., Autilio, T. M., Vicentini, E., Bimonte, V. M., Catanzaro, G., Pediconi, N., Fabi, A., et al. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.126422 · Cited by 14
Liu, Y., Chen, J., Yang, D., Liu, C., Tang, C., Cai, S., & Huang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-10186-9 · Cited by 14
Metabolomics in Breast Cancer: From Biomarker Discovery to Personalized Medicine
Perestrelo, R., & Luís, C. (2025) · Metabolites · doi:10.3390/metabo15070428 · Cited by 13
Monfaredan, A., Şen, S., Fathi, N. K., Taştekin, D., Hosseininasab, A., Bozbey, H. U., & Öncül, O. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178448 · Cited by 13
Hassan, M. M., Tahsin, A., Alam, M. G. R., Alzamil, D., Garg, S., Uddin, M. Z., Choudhury, N., & Fortino, G. (2025) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2025.109152 · Cited by 19
Tang, C., Tian, B., Zhang, B., Zhang, Y., Ke, C., Chen, M., Wei, M., Wang, W., Deng, X., Zhang, Q., et al. (2026) · ChemMedChem · doi:10.1002/cmdc.202501111 · Cited by 13
Local production of active vitamin D3 metabolites in breast cancer cells by CYP24A1 and CYP27B1
Dennis, C. D., Dillon, J., Cohen, D. J., Halquist, M. S., Pearcy, A. C., Schwartz, Z., & Boyan, B. D. (2023) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2023.106331 · Cited by 13
Glucose oxidase virus‐based nanoreactors for smart breast cancer therapy
Gama, P., Juárez, P., Rodríguez‐Hernández, A. G., & Vázquez-Duhalt, R. (2023) · Biotechnology Journal · doi:10.1002/biot.202300199 · Cited by 13
Pan, M., Solozobova, V., Kuznik, N. C., Jung, N., Gräßle, S., Gourain, V., Heneka, Y. M., von Clausbruch, C. A. C., Fuhr, O., Munuganti, R. S. N., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0111 · Cited by 13
Ti3C2T -Au hybrid composites-based electrochemical biosensors for calreticulin biomarker detection
Naz, G., Salem, M. A., Sharma, B. P., Mekkey, S. D., Soomro, R. A., Karakuş, S., & El-Bahy, Z. M. (2023) · Microchemical Journal · doi:10.1016/j.microc.2023.109307 · Cited by 13
Tenna, M., Okova, R., Habtu, M., Wondafrash, M., & Bekele, A. (2023) · BMC Women s Health · doi:10.1186/s12905-023-02776-4 · Cited by 13
Bailey, L. E., & Morris, M. A. (2023) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2023.101811 · Cited by 13
Targeting cancer stem cell plasticity in triple-negative breast cancer
Guo, Z., & Han, S. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00190 · Cited by 18
Immunotherapy: Constructive Approach for Breast Cancer Treatment
Anayyat, U., Ahad, F., Muluh, T. A., Zaidi, S. H. E., Usmani, F., Yang, H. W., Li, M., Hassan, H. A., & Wang, X. (2023) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s424624 · Cited by 14
Sanz-Álvarez, M., Luque, M., Morales-Gallego, M., Cristóbal, I., Ramírez-Merino, N., Rangel, Y., Izarzugaza, Y., Eroles, P., Albanell, J., Madoz‐Gúrpide, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010207 · Cited by 13
Aghabagherzadeh, M., Karimi, E., & Zareian, M. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202300187 · Cited by 13
Chittasupho, C., Samee, W., Takuathung, M. N., Okonogi, S., Nimkulrat, S., & Athikomkulchai, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020978 · Cited by 13
Ramos, P. G. F., Júdice, P. B., Nobre, I., & Carraça, E. V. (2024) · Journal of Cancer Survivorship · doi:10.1007/s11764-024-01545-y · Cited by 17
Mohanty, A., Lee, M., Mohapatra, A., Lee, H., Vasukutty, A., Baek, S., Lee, J. Y., & Park, I. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202304093 · Cited by 13
Article review: Brazilin as potential anticancer agent
Raptania, C. N., Zakia, S., Fahira, A. I., & Amalia, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1355533 · Cited by 16
Youssef, A., Moa, B., & El-Sharkawy, Y. H. (2024) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2024.104048 · Cited by 13
Gharavi, A. T., Irian, S., Niknejad, A., Parang, K., & Salimi, M. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200800 · Cited by 13
Al-Fatlawi, I. N. A. A., Pouresmaeil, V., Davoodi‐Dehaghani, F., Pouresmaeil, A., Akhtari, A., & Tabrizi, M. H. (2024) · BMC Biotechnology · doi:10.1186/s12896-024-00845-6 · Cited by 13
Zewdie, A., Kassie, T. D., Anagaw, T. F., Mazengia, E. M., Gelaw, S. S., Fenta, E. T., Eshetu, H. B., Kebede, N., & Bogale, E. K. (2024) · BMC Women s Health · doi:10.1186/s12905-024-03133-9 · Cited by 13
Li, W., Guo, Y., Xu, Z., Li, F., Dong, Y., & Xu, F. (2024) · Aging · doi:10.18632/aging.205940 · Cited by 13
Gupta, P., Sharma, S., Gupta, A., Kawish, S. M., Iqbal, M., Rahman, S., Aqil, M., Kohli, K., & Sultana, Y. (2024) · ACS Omega · doi:10.1021/acsomega.3c08078 · Cited by 13
Karzoon, A., Yerer, M. B., & Cumaoğlu, A. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03316-z · Cited by 13
Bilski, M., Konat-Bąska, K., Zerella, M. A., Corradini, S., Hetnał, M., Leonardi, M. C., Gruba, M., Grzywacz, A., Hatala, P., Jereczek‐Fossa, B. A., et al. (2024) · Radiation Oncology · doi:10.1186/s13014-024-02497-4 · Cited by 13
Shi, J., Chen, Y., Cai, Z., Heidari, A. A., Chen, H., & He, Q. (2024) · Cluster Computing · doi:10.1007/s10586-024-04644-8 · Cited by 13
Jyothi, G., Palabindela, R., & Narsimha, S. (2024) · Russian Journal of General Chemistry · doi:10.1134/s1070363224060239 · Cited by 13
Liu, W., An, J., Jiao, C., Zhi, L., Guo, J., & Sun, L. (2024) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2024.108647 · Cited by 13
Dubey, A., Alanazi, A. M., Bhardwaj, R., & Ragusa, A. (2024) · Molecular Diversity · doi:10.1007/s11030-024-10950-5 · Cited by 13
Senescence-related genes as prognostic indicators in breast cancer survival
Ungvari, Z. I., Ungvari, A., Fekete, M., Kiss, C., & Győrffy, B. (2024) · GeroScience · doi:10.1007/s11357-024-01384-w · Cited by 14
Current Therapeutic Opportunities for Estrogen Receptor Mutant Breast Cancer
Palaniappan, M. (2024) · Biomedicines · doi:10.3390/biomedicines12122700 · Cited by 14
Oghenejoboh, U. M., Sonibare, O. O., Waseem, M., Ekundayo, O., Haq, S., Alsaiari, A. A., & Razzokov, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e40759 · Cited by 14
Lee, S.-W., Kim, H.-Y., Jang, S., Kim, W., Kim, C., Lee, J., Ryoo, Z. Y., Han, J. E., Baek, S.-M., Park, J.-K., et al. (2025) · Journal of environmental chemical engineering · doi:10.1016/j.jece.2025.115473 · Cited by 17
Erdoğan, M. K., Toy, Y., Gündoğdu, R., Geçibesler, İ. H., SEVER, A., Yapar, Y., Behçet, L., & Zengin, G. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106082 · Cited by 13
Accurate phenotyping of luminal A breast cancer in magnetic resonance imaging: A new 3D CNN approach
Fontes, J. P. P., Raimundo, J. N. C., Magalhães, L., & Guevara, M. A. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109903 · Cited by 14
Kharazi, D. M., Karam, L., Boustany, C. E., & Ibrahim, J.-N. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1535563 · Cited by 13
Pilard, C., Roncarati, P., Ancion, M., Luyckx, M., Renard, M., Reynders, C., Lerho, T., Poulain, F., Bruyère, D., Lebeau, A., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010753 · Cited by 16
Augimeri, G., & Bonofiglio, D. (2023) · Molecules · doi:10.3390/molecules28093694 · Cited by 13
Synthesis of New Chromene Derivatives Targeting Triple-Negative Breast Cancer Cells
Alneyadi, A. H., Nizami, Z. N., Aburawi, H. E., Hisaindee, S., Nawaz, M., Attoub, S., Ramadan, G. A., Benhalilou, N., Azzani, M. A., Elmahi, Y., et al. (2023) · Cancers · doi:10.3390/cancers15102682 · Cited by 14
Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020
Leong, E., Ong, S. K., Si-Ramlee, K. A., & Naing, L. (2023) · BMC Cancer · doi:10.1186/s12885-023-10962-8 · Cited by 13
Starodubtseva, N. L., Tokareva, A., Родионов, В. В., Brzhozovskiy, A. G., Bugrova, A. E., Chagovets, V., Кометова, В. В., Kukaev, E., Soares, N. C., Kovalev, G. I., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11071786 · Cited by 13
Rudat, V., Zhao, R., Wang, B., Zhang, L., & Shi, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-77482-8 · Cited by 12
Hamilton, E. P., Loibl, S., Bachelot, T., Gnant, M., Niikura, N., Park, Y. H., Tolaney, S. M., Pistilli, B., Rastogi, P., Saini, K. S., et al. (2025) · Future Oncology · doi:10.1080/14796694.2025.2459548 · Cited by 17
Mohammadzadeh, S., Mohebbi, A., Moradi, Z., Abdi, A., Mohammadi, A., Hakim, P. K., Ahmadinejad, N., & Zeinalkhani, F. (2025) · European Journal of Radiology · doi:10.1016/j.ejrad.2025.112055 · Cited by 12
Wang, M., Gao, Z.-X., Zhao, R., Zhou, P., Chen, J., Zhang, H., Wang, Y., Zhu, W., & Gao, P. (2025) · Advanced Science · doi:10.1002/advs.202410386 · Cited by 12
LLM-powered breast cancer staging from PET/CT reports: a comparative performance study
Spitzl, D., Mergen, M., Braren, R., Endrös, L., Eiber, M. J., & Steinhelfer, L. (2025) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2025.106053 · Cited by 12
HPV–driven breast carcinogenesis: associations with tumor severity, Ki67 expression and metastasis
Awan, U. A., Bashir, S., Hassan, U., Khan, S. N., Awan, F. M., Jabbar, A., Khan, S., & Guo, X. (2025) · Infectious Agents and Cancer · doi:10.1186/s13027-025-00668-w · Cited by 12
Khatri, R. B., Endalamaw, A., Darssan, D., & Assefa, Y. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0329854 · Cited by 12
A Review on Breast Cancer Detection for Histopathology Images Using Deep Learning
Ramalakshmi, E., Gunisetti, L., & Sumalatha, L. (2023) · International Conference on Artificial Intelligence and Smart Communication (AISC) · doi:10.1109/aisc56616.2023.10085116 · Cited by 12
Mazuráková, A., Koklesová, L., Výbohová, D., Samec, M., Kúdela, E., Biringer, K., Šudomová, M., Hassan, S. T. S., Kello, M., Büsselberg, D., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1160068 · Cited by 12
Echarri, A. A., Struszczak, L., Beresford, M. J., Campbell, J. P., Thompson, D., & Turner, J. E. (2023) · Frontiers in Sports and Active Living · doi:10.3389/fspor.2023.1163182 · Cited by 14
Mammary carcinoma: Comparative oncology between small animals and humans—New therapeutic tools
Frenel, J., & Nguyen, F. (2023) · Reproduction in Domestic Animals · doi:10.1111/rda.14408 · Cited by 12
Lapointe, J., Côté, J.-M., Mbuya-Bienge, C., Dorval, M., Pashayan, N., Chiquette, J., Eloy, L., Turgeon, A., Lambert-Côté, L., Brooks, J. D., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13071027 · Cited by 12
Quispe, Y. N. G., Kim, S., Saeidi, S., Zhou, T., Zheng, J., Kim, S. H., Fang, X., Chelakkot, C., Rios-Castillo, M. E., Shin, Y. K., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.020 · Cited by 14
Martínez-Miranda, P., Jiménez‐Rejano, J., Rosales‐Tristancho, A., & Casuso-Holgado, M. J. (2023) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2023.102411 · Cited by 12
Probing Aberrantly Glycosylated Mucin 1 in Breast Cancer Extracellular Vesicles
Saroj, S., Paul, D., Ali, A., Andreou, C., Pal, S., & Rakshit, T. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00651 · Cited by 12
El‐Ashmawy, N. E., Khedr, E. G., Abo-Saif, M. A., & Hamouda, S. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122339 · Cited by 12
Li, M., Yao, L.-Q., Liu, X., Tan, J.-Y. B., & Wang, T. (2024) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2024.100380 · Cited by 12
Menyhárt, O., Fekete, J. T., & Győrffy, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021063 · Cited by 12
Masoudinia, S., Samadizadeh, M., Safavi, M., Bijanzadeh, H. R., & Foroumadi, A. (2024) · BMC Chemistry · doi:10.1186/s13065-024-01119-0 · Cited by 12
Sala-Hamrick, K. E., Tapaswi, A., Polemi, K. M., Nguyen, V. K., & Colacino, J. A. (2024) · Environmental Health Perspectives · doi:10.1289/ehp12886 · Cited by 12
Peng, J., Liu, X., Mao, Y., Lv, M., Ma, T., Liu, J., Zhou, Q., Han, Y., Li, X., & Wang, H. (2024) · Molecular Carcinogenesis · doi:10.1002/mc.23747 · Cited by 12
Metadata
- Authors
- Arnold, M., Morgan, E., Rumgay, H., Mafra, A., Singh, D., Laversanne, M., Vignat, J., Gralow, J. R., Cardoso, F., Siesling, S., & Soerjomataram, I.
- Affiliations
- Centre international de recherche sur le cancer (FR)
- American Society of Clinical Oncology (US)
- Netherlands Comprehensive Cancer Organisation (NL)
- Corresponding author
- Morgan, Eileen
- ORCID
- Venue
- The Breast
- Publisher
- Elsevier BV
- Published
- 2022-12
- Volume
- 66
- Pages
- 15-23
- ISSN
- 0960-9776 (ISSN-L)
- PMC
- PMC9465273
- OpenAlex
- W4294189863
- Cited by
- 3,411
- References
- 43
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 997 · 2023: 516 · 2022: 23
- FWCI
- 284.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The Breast (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- University of Twente Research Information (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Twente Research Information (submittedVersion, cc-by-nc-nd)
- Funders
- Susan G. Komen (CCR19608129)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- breast cancer, global burden of disease, incidence, mortality, age-standardized rates, population projections, 2040 projections, regional variation, human development, cancer epidemiology
- MeSH terms
- Australia, Breast Neoplasms, Europe, Female, Forecasting, Humans, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review